The opportunity within the pre-sterilized / ready-to-use primary packaging market is projected to be worth USD 27 billion by 2030, claims Roots Analysis

 

 

Driven by the rising complexity of therapeutics, and the need to rapidly produce and package drug products, developers are gradually adopting pre-sterilized / ready-to-use packaging solutions

 

 

Roots Analysis has announced the addition of “Pre-Sterilized / Ready-to-Use Primary Packaging Market: Focus on Cartridges, Syringes, Vials and Closures (2nd Edition), 2021 – 2030” report to its list of offerings.

 

Pre-sterilized / ready-to-use (RTU) container-closure systems have emerged as a promising alternative to conventionally available packaging formats and have helped in expediting the fill / finish process, while offering substantial cost saving opportunities. Further, there has been an evident surge in demand for such systems during the ongoing COVID-19 pandemic for storage and packaging of the vaccines and experimental therapies. The demand for appropriate packaging solutions in adequate quantities, is likely to persist, significantly adding to the opportunity for RTU package and affiliated closure developers / suppliers.

 

To order this 310+ page report, which features 160+ figures and 220+ tables, please visit

https://www.rootsanalysis.com/reports/view_document/ready-to-use-primary-packaging-market/224.html

 

Key Market Insights

 

More than 150 pre-sterilized / RTU primary packaging systems are presently available in the market

Majority (50%) of these systems are pre-sterilized / RTU primary packaging closures, followed by containers (34%) and container-closure systems (16%). It is worth noting that glass is the preferred material for different types of pre-sterilized / RTU containers.

 

Around 50 companies, across the world, claim to be engaged in the manufacturing of pre-sterilized / RTU primary packaging systems

Majority of the firms (76%) are based in Europe and Asia Pacific. Further, 47% of the industry stakeholders are large and very large companies, followed by mid-sized companies (37%) and small players (16%).

 

Partnership activity within this domain has grown at a CAGR of 32%, between 2015 and 2020

Driven by the increased demand for pre-sterilized packaging systems amidst the COVID-19 pandemic, majority of the partnerships were established in 2020. A large number of these deals were inked for vials, followed by closures (22%), syringes (20%) and cartridges (18%).

 

The annual demand for pre-sterilized / RTU primary packaging systems is expected grow at an annualized rate of 7.3%

Currently, Asia Pacific and North America are estimated to contribute to more than 70% of the overall demand for pre-sterilized / RTU primary packaging systems. By 2030, the demand, in terms of number of RTU packaging systems, is projected to be over 220 billion. Further, glass containers hold the maximum share of the overall demand (82%), followed by plastic containers (18%).

 

North America and Europe are anticipated to capture ~58% of the market share, by 2030

The market in Asia Pacific is anticipated to grow at a relatively faster pace (8.6%), during 2021-2030. The market is currently driven by the sales of pre-sterilized / RTU syringes (51%), and pre-sterilized / RTU vials (18%). Further, pre-sterilized / RTU glass components currently capture 90% of the overall market share (in terms of sales based revenues).

 

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/view_document/ready-to-use-primary-packaging-market/224.html

 

Key Questions Answered

§  Who are the prominent players in the global pre-sterilized / ready-to-use primary packaging market?

§  What is the relative competitiveness of different ready-to-use primary packaging system manufacturers?

§  Which partnership models are most commonly adopted by stakeholders in this industry?

§  What is the likely impact of the ongoing COVID-19 pandemic on the global ready-to-use primary packaging systems market?

§  What is the current, global demand for ready-to-use containers and closures?

§  What are the major market trends and driving factors that are likely to impact the growth of ready-to-use primary packaging systems market?

§  How is the current and future opportunity likely to be distributed across key market segments?

 

The USD 25+ billion (by 2030) financial opportunity associated with pre-sterilized / ready-to-use primary packaging market has been analyzed across the following segments:

§  Type of Primary Packaging System

§  Vials

§  Syringes

§  Cartridges

§  Closures

 

§  Type of Fabrication Material Used

§  Glass

§  Plastic

 

§  Key Geographical Regions 

§  North America

§  Europe

§  Asia Pacific

§  Latin America

§  Middle East and North Africa

§  Rest of the World 

 

The report also features inputs from eminent industry stakeholders, according to whom, a significant increase in demand for vials and syringes is driving the growth of the pre-sterilized / ready-to-use primary packaging market. The report includes detailed transcripts of discussions held with the following experts:

§  Julien Marechal (Business Development and Technology Director, Aseptic Technologies)

§  Malcolm Gilmore (Facilitator, BioPhorum Operations Group)

§  Konstantin Kazarian (Former Project Manager of Business Development, PYRAMID Laboratories)

§  Daxesh Shah (Founder and Managing Director, Sagar Rubber)

 

The research includes profiles of key players (listed below), featuring a brief overview of the company, its financial performance (if available), recent developments and an informed future outlook.

§  AptarGroup

§  Datwyler Group

§  DWK Life Sciences

§  Gerresheimer

§  Ningbo Zhengli Pharmaceutical Packaging

§  Nipro

§  SCHOTT

§  SGD Pharma

§  Stevanato Group

§  Terumo Medical

§  Transcoject

§  West Pharmaceutical Services

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/view_document/ready-to-use-primary-packaging-market/224.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market: Industry Trends and Global Forecasts, 2021-2030

2.     Connected / Smart Drug Delivery Systems Market: Industry Trends and Global Forecasts, 2020-2030

3.     Diabetes Monitoring Devices Market: Industry Trends and Global Forecasts, 2020-2030

4.     Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

5.     Global Autoinjectors Market (3rd Edition), 2020-2030

6.     Prefilled Syringes Market (5th Edition), 2020-2030

 

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com

 

Comments

Post a Comment

Popular posts from this blog

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more

PRE-INSTALLED SINGLE-USE SENSORS FOR BIOPROCESSING-CASE STUDY

    During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing. The current market landscape is predominantly characterized by the presence of large (38%) and small (37%) players. Notable examples of large players in this domain include ( in alphabetical order ) Cytiva Life Sciences (US), Hamilton (US) and Pall (US).   To Request Sample Pages -: https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html       Majority of the pre-installed single-use sensor systems are designed for both, research and biomanufacturing purposes. This is followed by those designed for only research purposes. Notable examples of products which are developed for both research and biomanufacturing applications, include ( arranged alphabetically ) ÄKTA ready XL sensor technology (Cytiva Life Sciences), Allegro™ MVP Single-Use System (Pall Corporation) and FUTURA pico (Aber Instruments)...
Read more